{"database": "lobbying", "table": "lobbying_activities", "rows": [[2824633, "b4bf3c99-3a71-4b61-bb67-d1165b3c9509", "Q2", "DANA-FARBER CANCER INSTITUTE", 401106163, "DANA-FARBER CANCER INSTITUTE", 2022, "second_quarter", "MED", "Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including HR5030 / S2706 - The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act; HR623 / S1521 - Gabriella Miller Kids First Research Act 2.0; HR3089 / S1544 Accelerating Kids Access to Care Act; HR 6000, CURES 2.0 Act; H.R. 5585, the Advanced Research Project Agency-Health (ARPA-H) Act", "HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE", null, 78000, 0, 0, "2022-07-18T14:24:02-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2824633"], "units": {}, "query_ms": 33.87342090718448, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}